Break through the routine with PSI technology
The Sysmex® CS-5100 Hemostasis System is a random-access, high-volume coagulation analyzer. Simultaneous multiwavelength, smartly designed PSITM technology enables labs to achieve high-quality results on the first test run by identifying and managing unsuitable test specimens prior to analysis. Automated sample volume checks and qualitative detection of hemolysis, icterus, and lipemia1 minimize the need for manual sample inspection.
Fonctionnalités et avantages
Break through routine levels of performance with high precision in high-volume testing
The Sysmex CS-5100 System is a fully automated, high-volume hemostasis analyzer, enabling:
Multidisciplinary connectivity options allow customizable integration with automation solutions or stand-alone use, ideal for multisite labs.
The system uses pre-analytical checks of sample quality to identify and manage unsuitable samples for fewer reruns.
Optimized digital solutions
Whether hemostasis is fully integrated or stand-alone, Siemens Healthineers offers a wide range of digital solutions that help to optimize clinical operations.
White paper: Setting the stage for accurate results
The Sysmex CS-5100 System supports more-reliable results using PSI technology. However, there are additional pre-analytical variables associated with coagulation testing that also must be considered.
Complete the form to download the white paper: Pre-analytical Variables in Routine Coagulation Testing: Setting the Stage for Accurate Results.
Watch customer stories about hemostasis testing excellence
Swipe through and watch the videos to learn how two facilities benefit from connecting hemostasis systems to an automation solution.
Providing specialty tests 24/7
See how connecting Aptio® Automation to the Sysmex CS-5100 System enabled the laboratory at Kantonsspital Aarau to run FVIII and FXIII2 testing at any time.
Take a tour of system features
The Sysmex CS-5100 System offers high-volume and multisite labs advanced operational options to help achieve streamlined workflow and high-quality test results on the first run.
A wide variety of hemostasis systems fit the needs of any-size and multisite labs
- Shared reagents, consumables,6 controls, and calibrators simplify purchases for multisite labs
- Similar user software minimizes training requirements for multisite users.
- Results correlate with the Sysmex CS-2500 and CA-600 hemostasis systems.
6Excludes Sysmex CA-620/660 Systems cuvettes.
The Sysmex CS-5100 System offers an expansive test menu of routine and specialty hemostasis assays (including several INNOVANCE assays), all on a single instrument, allowing labs to run more tests per sample while processing a higher number of samples.
Expand to explore key specifications and learn about features of the Sysmex CS-5100 System.
Avez-vous jugé cette information utile?
1 The products/features are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed.
2 The products/features/applications mentioned here are not commercially available in all countries and are subject to local regulations. Their future availability cannot be guaranteed. Not available for sale in the U.S.
3 Throughput values were determined by the time to first result; processing capability varies depending on the reagent used. Throughput values stated above were determined using Siemens Healthineers study protocol with PT (Thromborel® S Reagent) and APTT (Pathromtin® SL Reagent) test applications.
4 Based on internal validation data from Sysmex Corporation.
5 HYPHEN BioMed application. The products/features are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details. In the U.S., platelet aggregation testing is for research use only, not for use in diagnostic procedures.
6 Excludes Sysmex CA-620/660 Systems cuvettes.
7 The INNOVANCE VWF Ac assay is under review by the FDA as a de novo classification request. An approval is pending and the product is not yet commercially available in the United States. Product availability may vary from country to country and is subject to varying regulatory requirements.
8 Throughput values were determined by the time to first result; processing capability varies depending on the reagent used. Throughput values stated above were determined using Siemens’ study protocol with PT (Thromborel® S Reagent), APTT (Pathromtin® SL Reagent), INNOVANCE® D-Dimer Reagent, and AT (INNOVANCE AT Reagent) test applications.
Aptio, Atellica, INNOVANCE, Pathromtin, PSI, Thromborel, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. Sysmex is a registered trademark of the Sysmex Corporation. All other trademarks and brands are the property of their respective owners.
Aptio Automation is manufactured by Inpeco SA and is exclusively distributed by Siemens Healthcare Diagnostics Inc.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.